The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers in the country.

During the past decade, University of Texas/MD Anderson CRC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 10 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Texas/MD Anderson CRC" #1 collaborator was "Blood and Marrow Transplant Clinical Trials Network" with 13 trials as a collaborator, "National Cancer Institute (NCI)" with 12 trials as a collaborator, "National Marrow Donor Program" with 11 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator and "Dana-Farber Cancer Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "University of Texas/MD Anderson CRC" are "Leukemia" (3 trials), "Multiple Myeloma" (3 trials), "Lymphoma" (2 trials), "Allogeneic Hematopoietic Stem Cell Transplantation" (1 trials) and "Anemia, Aplastic" (1 trials). Many other conditions were trialed in "University of Texas/MD Anderson CRC" in a lesser frequency.

Most popular intervention types in "University of Texas/MD Anderson CRC" are "Drug" (10 trials), "Procedure" (5 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (3 trials), "Lenalidomide" (2 trials), "Melphalan" (2 trials), "Alemtuzumab" (1 trials) and "Allogeneic HSCT" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Texas/MD Anderson CRC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "University of Texas/MD Anderson CRC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in University of Texas/MD Anderson CRC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Texas/MD Anderson CRC, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".